logo

For the Inventor, By the Inventor

Calgary, Canada

Oncolytics Biotech Inc.


USPTO Granted Patents = 65

% Expired Patents = 26.2



Trademarks = 3

Forward Citations = 652

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Matthew C Coffey (62 out of 65 patents)

silverMedal Bradley G Thompson (32 out of 151 patents)

bronzeMedal James Strong (13 out of 13 patents)

4.  Patrick W K Lee (12 out of 12 patents)

5.  Donald Morris (8 out of 8 patents)

6.  Leo Pavliv (4 out of 38 patents)

7.  Sarah Serl (4 out of 4 patents)

8.  Patrick W Lee (2 out of 2 patents)

9.  Ramon Alemany Bonastre (1 out of 7 patents)

10.  Hardev Pandha (1 out of 3 patents)

11.  Mathew C Coffey (1 out of 1 patent)

12.  Manel Maria Piqueras (1 out of 1 patent)

13.  Douglas Ball (1 out of 1 patent)

14.  Kara L Norman (1 out of 1 patent)

15.  Jyoti Latawa (1 out of 2 patents)


Core Competencies:
Reoviruses
Viral Purification
Neoplastic Cells
Cellular Proliferative Disorders
Chemotherapy Resistance
Infectious Reovirus
Lyophilized Formulations
Adventitious Agents
Radiation Therapy Sensitization
Cytokine Production
Viral Formulations
Cancer Treatment

65 patents:

1. 12655397 - Viral Extraction from Cell Culture (2026-06-16),
2. 11246930 - Reoviruses having modified sequences (2022-02-15),
3. 10596260 - Reoviruses having modified sequences (2020-03-24),
4. 10167452 - Viral purification methods (2019-01-01),
5. 10039827 - Reoviruses having modified sequences (2018-08-07),
6. 9610352 - Lyophilized viral formulations (2017-04-04),
7. 9610309 - Liquid viral formulations (2017-04-04),
8. 9365823 - Virus clearance of neoplastic cells from mixed cellular compositions (2016-06-14),
9. 9045728 - Liquid viral formulations (2015-06-02),
10. 9044498 - Lyophilized viral formulations (2015-06-02),
11. 8709443 - Reovirus for the treatment of cellular proliferative disorders (2014-04-29),
12. 8691241 - Reoviruses having modified sequences (2014-04-08),
13. 8685734 - Viral purification methods (2014-04-01),
14. 8658158 - Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus (2014-02-25),
15. 8512712 - Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions (2013-08-20),
Oncolytics Biotech Inc., based in Calgary, Canada, specializes in the development of oncolytic virus therapies for cancer treatment. The company focuses on harnessing the potential of reoviruses to target and destroy neoplastic cells while addressing challenges such as chemotherapy resistance. Their innovative approach includes viral purification and the creation of lyophilized formulations, positioning them at the forefront of research in cellular proliferative disorders and infectious reovirus applications.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Oncolytics Biotech Inc.
65 Patents

#11 in Calgary

#209 in Canada

#11,318 in the World

Calgary, CA
Calgary, Canada

Oncolytics Biotech Inc.

Forward Citations = 652

20 inventors:

goldMedal Matthew C Coffey (62 out of 65 patents)

silverMedal Bradley G Thompson (32 out of 151 patents)

bronzeMedal James Strong (13 out of 13 patents)

4.  Patrick W K Lee (12 out of 12 patents)

5.  Donald Morris (8 out of 8 patents)

Please report any incorrect information to [email protected]
Loading…